Undersized, oversized? It is not one-size-fits-all in lymphoid clonality detection

Area of Science:

• Molecular diagnostics
• Hematology
• Oncology

Background:

• Immunoglobulin (Ig) and T-cell receptor (TCR) gene rearrangements are crucial for lymphoid malignancy clonality assessment.
• Polymerase Chain Reaction (PCR) techniques are widely used for detecting these rearrangements in routine laboratories.

Discussion:

• Expected size ranges for Ig/TCR PCR products are important but should not be interpreted too rigidly.
• "Undersized" and "oversized" PCR products can still represent genuine clonal rearrangement events.
• Strict adherence to size ranges may lead to misclassification of true positives as negatives.

Key Insights:

• Accurate interpretation of Ig/TCR clonality testing is essential for diagnosing lymphoid malignancies.
• Flexibility in interpreting PCR product sizes is necessary to avoid false negatives.
• Close interaction between scientists is recommended for optimal diagnostic accuracy.

Outlook:

• Standardization of interpretation guidelines for Ig/TCR clonality testing is needed.
• Further research into the biological significance of "aberrant" sized rearrangement products is warranted.
• Enhanced training for laboratory scientists on nuanced interpretation of clonality assays will improve diagnostic outcomes.